Delivery Order SPE2DB22D3501-SPE2DB25FXF55
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Sunitinib Malate 50 mg capsules (28-count packages) with a ceiling value of $22,358.72. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, represents a competitively awarded, non-set-aside contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $10,805.88 firm fixed-price contract is for the supply of sunitinib malate 50 mg capsules. The award is not associated with a set-aside requirement. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $24,907.53 delivery order on August 11, 2025, by the Defense Logistics Agency's Medical Supply Chain, with final completion targeted for August 12, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child award under the company's larger Indefinite Delivery Contract vehicle. The delivery order falls under...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $5,446.79 to AmerisourceBergen Drug Corp on August 29, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $10,447.93 to AmerisourceBergen Drug Corp on July 28, 2025, for pharmaceutical and medical supply products. This firm fixed-price, non-set-aside contract is classified as a child award under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion comprehensive global pharmaceutical support vehicle running through December 2026. The delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $4,893.28 to AmerisourceBergen Drug Corp on September 1, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order, issued as a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle, represents a small pharmaceutical procurement. The award was not set-aside and was competitively awarded, reflecting the vendor's established capability...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $14,672.43 to AmerisourceBergen Drug Corp on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor's Corporate Office division. The contract will be performed at AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. As a child order under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $452,841.60 on September 8, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This competitive award, which is not set-aside, is structured as a firm fixed price delivery order with an ultimate completion date of September 9, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $918,679.83 to AmerisourceBergen Drug Corp on September 1, 2025, with completion targeted for September 2, 2025. This firm fixed-price delivery order, issued without set-aside provisions, represents a competitive award to the pharmaceutical distributor for medical supplies to support military healthcare operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $179,628.39 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award carries no set-aside...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXF55Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Sunitinib Malate 37.5 mg capsules (28-count) with a ceiling value of $9,141.79. This is a firm fixed price delivery order with no set-aside designation, completed competitively. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 10, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has established itself as a critical vendor for federal medical procurement through the Defense Logistics Agency and its Medical Supply Chain. The company's extensive portfolio of federal contract awards demonstrates its capability to deliver a wide range of pharmaceutical products across multiple therapeutic domains, from brand-name and generic medications to vaccines and specialized medical supplies. All of AmerisourceBergen's reviewed contract awards have been competitively awarded with firm fixed pricing, reflecting the company's ability to meet federal procurement requirements in open competition and support military healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.1k | 9/9/25 |